Several year ago, IMARC Research published a whitepaper outlining the differences between Drug and Medical Device clinical trials. Since IMARC focuses primarily on medical device trials, we felt it was important to highlight the differences between the two trials. It has proven to be one of our more popular whitepapers, so we have decided to offer everyone an infographic as a quick reference.
Understanding these similarities and appreciating the differences is important for clinical researchers who are involved in both drug and device trials. Clearly, the process of getting a drug or device approved is different, but both require an ethical commitment combined with the proper controls and an understanding the differences – in the details – between drugs and devices.
So while the investigations of drugs and devices have their differences, by design these differences are intended to accomplish the game goal: to safeguard those research participants while bringing safe and effective products to the market as quickly as possible.